Aurora Cannabis (ACB) EBT (2017 - 2026)

Aurora Cannabis (ACB) has reported EBT for 10 consecutive years, with -$2.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT rose 64.55% year-over-year to -$2.6 million in Q2 2026; TTM through Jun 2026 was -$29.6 million, a 371.48% decrease from a year earlier, with the FY2026 full-year figure at -$40.9 million, down 281.68% from the prior year.
• EBT was -$2.6 million for Q2 2026 at Aurora Cannabis, down from $8.3 million in the prior quarter.
• Over five years, EBT peaked at $67.1 million in Q1 2022 and troughed at -$540.1 million in Q4 2022.
• A 5-year average of -$88.2 million and a median of -$1.8 million in 2025 frame the typical range for EBT.
• Across the five-year window, EBT tumbled 59819.45% in 2022 and soared 554.79% in 2026, its largest moves.
• Over 5 years, EBT stood at -$540.1 million in 2022, then jumped by 97.67% to -$12.6 million in 2023, then soared by 257.82% to $19.9 million in 2024, then tumbled by 105.7% to -$1.1 million in 2025, then plunged by 131.76% to -$2.6 million in 2026.
• The last three EBT figures came in at -$2.6 million (Q2 2026), $8.3 million (Q1 2026), and -$1.1 million (Q4 2025), per Business Quant data.